22
35
35
35
Croatian, Thai, Kannada, Malay, Turkish, Mandarin, Spanish, German, French, Creole, Arabic, Tagalog, Portuguese, Māori, Samoan, Vietnamese, German, Hebrew, Italian
AIDN, AusBiotech, Austmine, BioMelbourne Network, BioNSW, CAMLA, Defence Teaming Centre, Energy Club WA, SA Business Chamber, The Law Society of WA, LESANZ, INTA, Copyright Society, Copyright Agency Limited, IPTA, WA Mining Club, The Law Society of WA, Pharma in Focus, ICON
Wrays offers a comprehensive suite of IP services designed to identify, protect, grow and defend intellectual property assets for clients of all sizes, from start-ups and SMEs to large corporates, universities, research institutions and government bodies.Its core capabilities include:
Patent Services: Conducting patentability and freedom-to-operate searches, drafting and filing patent applications, prosecution, and enforcement strategy.
Trade Marks and Brand Protection: Registering and managing trade marks, designing brand protection strategies, handling domain name issues, and enforcing rights=
IP Management and Strategy: Advising on IP portfolio optimisation, commercialisation pathways, licensing, monetisation, and alignment of IP with business objectives.
Dispute Resolution and Litigation: Providing specialist litigation support, infringement defence, alternative dispute resolution, and strategic risk management.
Commercial and Technology Law: Drafting and negotiating commercial agreements and technology transactions
With offices in Sydney, Melbourne, Perth and Adelaide, Wrays serves clients across Australia and globally, offering integrated legal, technical and strategic IP solutions.
- Copyright
- Copyright & related rights
- Designs
- Intellectual property
- Intellectual property (contentious)
- Intellectual property (prosecution)
- IP transactions
- Life sciences IP
- Patent
- Patent (contentious)
- Patent (prosecution)
- PTAB litigation
- Trade mark
- Trade mark (contentious)
- Trade mark (prosecution)
- For more information click here
Natalie Shoolman
Intellectual property
E: natalie.shoolman@wrays.com.au- Represented Amgen Inc. in a landmark Australian patent case involving PCSK9 antibodies for lowering LDL cholesterol. Wrays secured a complete victory against Sanofi, with all patent challenges dismissed and costs awarded.
- Represented Amgen in proceedings against Sandoz Pty Ltd over biosimilar denosumab products, obtaining preliminary discovery and advancing patent infringement proceedings concerning Prolia and Xgeva.
- Secured Reckitt Benckiser as a client following a competitive tender process and now manages more than 840 registered trademarks and 22 registered designs across Australia and the Pacific Islands.
Gary Cox
Intellectual property
E: gary.cox@wrays.com.au- Acts for Conquest Crop Protection Pty Ltd in patent disputes relating to pyroxasulfone herbicide technology and related revocation proceedings.
- Represents a major agrochemical company in a Federal Court appeal concerning crystal form patent claims related to the herbicidal compound bixlozone.
- Successfully represented Amgen Inc. in the landmark Australian PCSK9 antibody patent litigation against Sanofi.
Tyson Keed
Patent
E: tyson.keed@wrays.com.au- Advises Neometals Ltd on patent drafting, filing and prosecution for over 45 patent applications covering lithium refining, battery recycling, zeolite synthesis, and titanium and vanadium processing.
- Acts for Talga Resources Ltd in developing and managing strategic intellectual property protection and commercialisation programs.
- Manages Bunnings Group Limited’s intellectual property portfolio, including more than 650 registered trademarks and 175 active filings.
Todd Shand
Life sciences IP
E: todd.shand@wrays.com.au- Advises Rumin8 on international patent strategy for methane-reducing livestock feed technology.
- Represents Amgen in Federal Court denosumab biosimilar patent litigation involving Sandoz.
- Acts for Conquest Crop Protection Pty Ltd in high-value agrochemical patent disputes involving pyroxasulfone technology.
- Grant Shoebridge
Life sciences IP
E: grant.shoebridge@wrays.com.au- Selected by a global pharmaceutical company for Australian pre-litigation work relating to patents covering a blockbuster drug.
- Leads a confidential pre-litigation and patent opposition matter involving gene-editing technology.
- Leads prosecution of Illumina’s Australian patent portfolio covering DNA sequencing instruments, genomic technologies, and related innovations.
- Aerospace
- Agriculture
- Artificial intelligence
- Automotive
- Aviation
- Biotechnology
- Chemical
- Computer technology & services
- Construction and materials
- Consumer goods and services
- Defence
- E-commerce
- Electrical
- Electronics
- Energy
- Fashion & luxury goods
- Fisheries and aquaculture
- FMCG
- Food and beverage
- Forestry
- Furniture
- Gaming
- Government and public policy
- Healthcare
- Hospitality & leisure
- ICT & software
- Industrials
- Instruments
- Internet
- Life sciences
- Manufacturing
- Mechanical
- Media
- Medical device
- Mining
- Nanotechnology
- Natural resources
- Not-for-profit
- Oil and gas
- Optics & photonics
- Pharmaceutical
- Professional services
- Publishing
- Renewable energy
- Retail
- Robotics
- Semiconductors
- Shipping
- Social infrastructure
- Sports
- Technology hardware
- Telecommunication
- Tobacco
- Transport
- Universities & research
- Utilities
- For more information click here
- SYDNEY OFFICE
Level 20, 1 Castlereagh Street
Sydney
2000
Australia
T: +61 2 8415 6500
E: marketing@wrays.com.au
W: https://wrays.com.au - MELBOURNE OFFICE
Level 20, 600 Bourke Street
Melbourne
3000
Australia
T: +61 3 8538 5800
E: marketing@wrays.com.au
W: https://wrays.com.au - ADELAIDE OFFICE
78 North Terrace
Kent Town
5067
Australia
T: +61 8 9216 5100
E: marketing@wrays.com.au
W: https://wrays.com.au